Trial Profile
Amonafide: Individual Phenotype-Adjusted Chemotherapy for Women With Metastatic Breast Cancer Who Have Progressed Despite Prior Chemotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Amonafide (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 01 Oct 2014 New trial record